Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 3Other 2

Conditions

Xerostomia 2Squamous Cell Carcinoma of Head and Neck 2Radiation Injuries 2Mucositis 2Head and Neck Neoplasms 2Salivary Gland Neoplasms 1Deglutition Disorders 1

Interventions

Radiotherapy 4Radiation 3Cisplatin 3Amifostine 2pegfilgrastim 1Surgical Procedures, Operative 1Selenomethionine 1Paclitaxel 1Oral Hygiene 1Low-Level Light Therapy 1Lansoprazole 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Filgrastim 1Fibroblast Growth Factor 7 1Docetaxel 1Dexlansoprazole 1Carboplatin 1Biotene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Xerostomia × Amifostine × Other × Clear all
NCT00503776 2017-06-20

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
41 enrolled 12 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

NCT00095927 2017-01-04

Randomized Amifostine For SCCHN

Dana-Farber Cancer Institute

Phase 2 Completed
58 enrolled
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Radiation Injuries, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡